((5-bromo-4-(4-cyclopropyl-1-naphthyl)-4H-1,2,4-triazol-3-yl)sulfanyl)acetic acid,
lesinurad,
RDEA594,
Zurampic,
LESINURAD,
878672-00-5,
RDEA594,
Zurampic,
RDEA 594,
RDEA-594,
UNII-09ERP08I3W,
2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid,
09ERP08I3W,
AK323774,
2-(5-Bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid,
C17H14BrN3O2S,
{[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid,
2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid,
2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetic acid,
Lesinurad [USAN:INN],
Zurampic (TN),
2-{[5-broMo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid,
Lesinurad (USAN/INN),
Lesinurad (RDEA594),
Lesinurad (RDEA-594),
SCHEMBL842962,
GTPL7673,
Lesinurad (RDEA594 pound(c),
CHEMBL2105720,
Lesinurad, >=98% (HPLC),
BDBM37953,
CHEBI:90929,
KS-00000LAE,
FGQFOYHRJSUHMR-UHFFFAOYSA-N,
BCP06435,
EX-A1289,
US10093631, Compound Lesinurad,
3777AH,
MFCD22572730,
s4640,
ZINC84757007,
AKOS027327368,
ACN-050764,
CS-1389,
DB11560,
SB16705,
AC-29310,
HY-15258,
SC-94287,
D09921,
W-5949,
(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid,
2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid,
2-[[5-Bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic acid,
Acetic acid, 2-((5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl)thio)-,
Acetic acid,[[5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-,
Lesinurad [USAN],
RDEA594 SODIUM,
D0C3SW,
A3549,
A12981,